Seventy-one percent of counties that spray the most glyphosate have late-stage non-Hodgkin lymphoma incidence rates above the national average, according to a new data analysis from the advocacy group ...
Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. Australian tech entrepreneur Paul Conyngham has used artificial intelligence tools to help design a personalized mRNA ...
If there’s one universal experience with AI-powered code development tools, it’s how they feel like magic until they don’t. One moment, you’re watching an AI agent slurp up your codebase and deliver a ...
Abstract: Accurate liver and tumor segmentation in CT images is vital for diagnosis and treatment planning. This study presents SegResNet_2335, a lightweight 3D residual network optimized for ...
Researchers are engineering bacteria to invade tumors and consume them from the inside. Because tumor cores lack oxygen, they’re the perfect breeding ground for these microbes. The team added a ...
What Is It, and Why Does It Matter? Rybrevant Faspro is a new under-the-skin (subcutaneous, or SC) injection form of the anticancer medicine Rybrevant (amivantamab). The FDA has now approved it in ...
When shutting down the Triton Inference Server with Python backend while using Triton metrics, a segmentation fault occurs in python_backend process. This happens because Metric::Clear attempts to ...
After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by the FDA. In rejecting RGX-121, the FDA raised concerns about its clinical ...
Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs. Metastasis is ...
Nearly half of cancers could be avoided by cutting out three major risk factors, a new study has revealed. Research published this week in Nature Medicine identified that nearly 40% of global cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results